..and another suggestion if I may... melatonin is a hormone involved( amongst many other functions) in regulating the circadian rithms ! It is supposed to be taken 20 min before going to sleep and never later than 2 am as our bodies do not produce melatonin much later than that ..and I was reading that it might be even harmful to supplement with melatonin later than 2 am and of... Voir plus
..and another suggestion if I may... melatonin is a hormone involved( amongst many other functions) in regulating the circadian rithms ! It is supposed to be taken 20 min before going to sleep and never later than 2 am as our bodies do not produce melatonin much later than that ..and I was reading that it might be even harmful to supplement with melatonin later than 2 am and of course during the day when our bodies do not secrete this hormone... so I suggest using this Ic late evening and removing melatonin for during the day... following is a little copy paste ab melatonin;”Taking too much melatonin can actually cause rebound insomnia —either rendering the supplement ineffective or worse, exacerbating your already sleepless nights further. You only need tiny doses of melatonin to support your natural sleep cycle.”... hope this is helpful! Melatonin is released by the body during the dark hours not during the day! Stay well!
Voir la traduction
Welcome to our vibrant online community, where we encourage members to share their personal experiences and insights to foster collective growth and mutual support in our journey towards well-being.
Doris Loh has made significant contributions to research on melatonin, particularly in its roles in health and disease management. Her work has focused on understanding melatonin's interaction with biomolecular condensates, which are involved in several neurodegenerative disorders and other health issues. Loh's research suggests that melatonin can regulate the formation and function of these condensates,... Voir plus
Doris Loh has made significant contributions to research on melatonin, particularly in its roles in health and disease management. Her work has focused on understanding melatonin's interaction with biomolecular condensates, which are involved in several neurodegenerative disorders and other health issues. Loh's research suggests that melatonin can regulate the formation and function of these condensates, potentially offering therapeutic benefits for diseases characterized by aberrant protein aggregation, such as Alzheimer's (Melatonin Research).
She has also explored the use of melatonin in the context of cancer, prions, and viral infections like SARS-CoV-2. Her findings indicate that melatonin acts as a metabolic buffer, potentially halting the stress-feedback cycles linked to these conditions (MelatoninDosage). Additionally, Loh has revised melatonin dosage guidelines based on new insights into its biochemical interactions during the COVID-19 pandemic (MelatoninDosage).
Loh's work is pioneering in its examination of ancient molecules like melatonin, viewing them through a modern scientific lens to uncover potential new applications for health and disease treatment (Melatonin2023). Her research series on "Melatonin in Health and Disease" offers a comprehensive overview of these concepts, discussing the never-before-seen features of melatonin and its significance in modern medicine (Melatonin2023).
For more detailed insights into her research, you can visit her publications on her website Doris Loh's Research.
Doris Loh a apporté d'importantes contributions à la recherche sur la mélatonine, en particulier dans son rôle dans la santé et la gestion des maladies. Ses travaux se sont concentrés sur la compréhension de l'interaction de la mélatonine avec les condensats biomoléculaires, impliqués dans plusieurs troubles neurodégénératifs et d'autres problèmes de santé. Les recherches de Loh suggèrent... Voir plus
Doris Loh a apporté d'importantes contributions à la recherche sur la mélatonine, en particulier dans son rôle dans la santé et la gestion des maladies. Ses travaux se sont concentrés sur la compréhension de l'interaction de la mélatonine avec les condensats biomoléculaires, impliqués dans plusieurs troubles neurodégénératifs et d'autres problèmes de santé. Les recherches de Loh suggèrent que la mélatonine peut réguler la formation et la fonction de ces condensats, offrant potentiellement des avantages thérapeutiques pour les maladies caractérisées par une agrégation aberrante des protéines, comme la maladie d'Alzheimer ( Melatonin Research ).
Elle a également exploré l’utilisation de la mélatonine dans le contexte du cancer, des prions et des infections virales comme le SRAS-CoV-2. Ses découvertes indiquent que la mélatonine agit comme un tampon métabolique, interrompant potentiellement les cycles de retour de stress liés à ces conditions ( MelatoninDosage ). De plus, Loh a révisé les directives de dosage de la mélatonine sur la base de nouvelles connaissances sur ses interactions biochimiques pendant la pandémie de COVID-19 ( MelatoninDosage ).
Le travail de Loh est pionnier dans l'examen de molécules anciennes comme la mélatonine, en les examinant à travers une lentille scientifique moderne pour découvrir de nouvelles applications potentielles pour la santé et le traitement des maladies ( Melatonin2023 ). Sa série de recherches sur « La mélatonine dans la santé et la maladie » offre un aperçu complet de ces concepts, discutant des caractéristiques inédites de la mélatonine et de son importance dans la médecine moderne ( Melatonin2023 ).
Pour un aperçu plus détaillé de ses recherches, vous pouvez consulter ses publications sur son site Web Doris Loh's Research .